Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction

Abstract

A markedly decreased aortic nitric oxide (NO) availability, probably due to impaired endothelial nitric oxide synthase activity with enhanced O₂- and peroxynitrite production, seems to be attributable to endothelial dysfunction in spontaneously hypertensive rats (SHR) with severe congestive heart failure (CHF). In this study, we investigated the chronic effect of the angiotensin-converting enzyme inhibitor, ramipril (RA) and the loop diuretic, frusemide (FU), as well as the combination of both on endothelial NO, O₂- and peroxynitrite production in aortae from SHR with failing hearts after myocardial infarction (MI).

Heart failure was induced by permanent occlusion of the left coronary artery. SHR were randomised to receive either placebo, RA, (1 mg/kg/day), FU (4 mg/kg/day) or RA+FU (1 and 4 mg/kg/day, respectively). Treatments were started two weeks following MI and continued for six weeks. Reduced aortic and coronary flow indices in the working heart, which can be considered as markers for endothelial function, were significantly normalised and improved, respectively, by RA, FU or RA+FU-treatment. Similarly, all three treatment regimens significantly enhanced the reduced calcium ionophore (CaI)-induced NO-release (assessed by a NO-sensitive microsensor) from aortic endothelial cells of placebo- treated animals with CHF. Concomitantly, the increased CaI-stimulated O₂production (assessed by an electrochemical sensor) in aortic endothelial cells of placebo-treated animals with CHF was significantly reduced by RA and RA+FUtreatment. Treatment with RA and RA+FU also attenuated the dramatic increase in endothelial peroxynitrite concentration (chemiluminescence method), which was observed in placebo-treated rats with CHF. FU did not counteract improved haemo- and cardiodynamic parameters by RA.

Thus, RA and FU act synergistically to enhance bioavailability of endothelium-derived NO, and this may contribute to the clinical usefulness of the combination of these drugs in treatment of heart failure.

Keywords

congestive heart failure ramipril frusemide nitric oxide superoxide spontaneously hypertensive rats

Get full access to this article

View all access options for this article.

References

Drexler H. , Hayoz D. , Münzel T. et al. Endothelial function in chronic heart failure. Am J Cardiol 1992;69:1596-601.

Katz SD , Biasucci L. , Sabba C. et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992;19:918-25.

Kaiser L. , Spickard RC , Olivier NB Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol 1989;256:H962-H967.

Drexler H. , Lu W. Endothelial dysfunction in hindquarter resistance vessels in experimental heart failure. Am J Physiol 1992;262:H1640-H1645.

Wiemer G. , Itter G. , Malinski T. , Linz W. Decreased nitric oxide availability in normotensive and hypertensive rats with failing hearts after myocardial infarction. Hypertension 2001;38:1367-71.

Bauersachs J. , Bouloumie A. , Fraccarollo D. , Hu K. , Busse R. , Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression. Circulation 1999;100:292-8.

Bauersachs J. , Fleming I. , Fraccarollo D. , Busse R. , Ertl G. Prevention of endothelial dysfunction in heart failure by vitamin E: attenuation of vascular superoxide anion formation and increase in soluble guanylyl cyclase expression. Cardiovasc Res 2001;51:344-50.

Katz SD , Khan T. , Zeballos GA et al. Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure. Circulation 1999;99:2113-17.

Pinsky DJ , Patton S. , Mesaros S. et al. Mechanical transduction of nitric oxide in the beating heart . Circ Res 1997;81:372-9.

10.

Balligand JL , Kobzik L. , Han X. et al. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 1995;270:14582-6.

11.

Vila-Petroff MG , Younes A. , Egan J. , Lakatta EG , Sollott SJ Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 1999; 84:1020-31.

12.

Drexler H. Nitric oxide synthases in the failing human heart. Circulation 1999;99:2972-5.

13.

Hajjar RJ , Schwinger RHG , Schmidt U. et al. Myofilament calcium regulation in human myocardium. Circulation 2000; 101:1679-85.

14.

SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.

15.

Yusuf S. , Sleight P. , Pogue J. , Bosch J. , Davies R. , Dagenais D. Effects of an angiotensin converting enzyme inhibitor , ramipril, on cardiovascular events in high risk patients: the heart outcomes prevention evaluation (HOPE) study investigators. Engl J Med 2000;342:145-53.

16.

Mulder P. , Elfertak L. , Richard V. et al. Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition. Am J Physiol 1996;271:H469-H477.

17.

Mulder P. , Devaux B. , Richard V. et al. Early versus delayed angiotensin converting enzyme inhibition in experimental chronic heart failure. Circulation 1997;95:1314-19.

18.

Pfeffer JM , Pfeffer MA , Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985;57:84-95.

19.

Richer C. , Mulder P. Fornes P. , Domergue V. , Heudes D. , Giudicelli JF Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats.JCardiovasc Pharmacol 1992;20:147-56.

20.

Linz W. , Wohlfart P. , Sckölkens BA , Malinski T. , Wiemer G. Interactions among ACE, kinins and NO. Cardiovasc Res 1999;43:549-61.

21.

Toyoshima H. , Nasa Y. , Kohsaka Y. et al.The effect of chronic treatment with trandolapril on cyclic AMP and cyclic GMPdependent relaxations in aortic segments of rats with chronic heart failure. Br J Pharmacol 1998;123:344-52.

22.

Varin R. , Mulder P. , Tamoin F. et al. Improvement of endothelial function by chronic angiotensin converting enzyme inhibition in heart failure. Circulation 2000;102.351-6.

23.

Lundergran CF , Fitzpatrick TM , Rose JC , Ramwell PW , Kot PA Effect of cyclooxygenase inhibition on the pulmonary vasodilator response to furosemide. J Pharmacol Exp Ther 1988;246:102-06.

24.

Tiam R. , Aalkjer C. , Andreasen F. Mechanisms behind the relaxing effect of furosemide on the isolated rabbit ear artery. Pharmacol Toxicol 1991;68:406-10.

25.

Wiemer G. , Fink E. , Linz W. , Hropot M. , Schölkens BA , Wohlfart P. Furosemide enhances the release of endothelial kinins, nitric oxide and prostacyclin . J Pharmacol Exp Ther 1994 ;271:1611-15.

26.

Murphey LJ , Kumar S. , Brown NJ Endogenous bradykinin and the renin and pressor responses to furosemide in humans. J Pharmacol Exp Ther 2000;295:644-8.

27.

Linz W. , Wohlfart P. , Sckölkens BA , Becker RHA , Malinski T. , Wiemer G. Late treatment with ramipril increases survival in old spontaneously hypertensive rats. Hypertension 1999;34: 291-5.

28.

Itter G. , Linz W. , Jung W. , Juretschke P. , Wiemer G. , Schölkens BA Severe symptomatic heart failure in spontaneously hypertensive rats . Hypertension 1998;32:Abstract 807.

29.

Malinski T. , Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 1992;358:676-8.

30.

Malinski T. , Czuchajowski L. Nitric oxide measurements by electrochemical methods. In: Feelish M , Stamler JS (eds.). Methods of Nitric Oxide Research. New York, NY: John Wiley & Sons, Inc. 1996;319-39.

31.

Lvovich V. , Scheeline A. Amperometric sensors for simultaneous superoxide and hydrogen peroxide detection . Anal Chem 1997;69:454-62.

32.

Mesaros S. , Vankova Z. , Grunfeld S. , Mesarosova A. , Malinski T. Preparation and optimization of superoxide microsensor. Anal Chim Acta 1998;358:27-31.

33.

Grow JP , Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: Implications for intracellular measurement of reactive nitrogen and oxygen and chemistry. Nitric Oxide 1997;1:145-57.

34.

Wiemer G. , Linz W. , Hatrik S. , Schölkens BA , Malinski T. Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats. Hypertension 1997;30:1183-90.

35.

Rajagopalan S. , Kurz S. , Münzel T. et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH activation. J Clin Invest 1996;97:1916-23.

36.

Griendling KK , Minieri CA , Ollerenshaw JD , Alexander RW Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-8.

37.

Wollert HC , Studer R. , von Bülow B. , Drexler H. Survival after myocardial infarction in the rat: role of tissue angiotensin converting enzyme inhibition. Circulation 1994;90:2457-67.

38.

Indik JH , Goldman S. , Gaballa MA Oxidative stress contributes to vascular endothelial dysfunction in heart failure. Am J Physiol Circ Physiol 2001 ;281:H1767-H1770.

39.

Hornig B. , Landmesser U. , Kohler C. et al. Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease. Circulation 2001;103:799-805.

40.

Linz W. , Jessen T. , Becker RHA , Schölkens BA , Wiemer G. Long-term ACE Inhibition doubles lifespan of hypertensive rats. Circulation 1997;96:3164-72.

41.

Shah AM , Lewis MJ , Henderson AH Effects of 8-bromocyclic GMP on contraction and on inotropic response of ferret cardiac muscle. J Mol Cell Cardiol 1991;23:55-64.

42.

Seeland U. , Kouchi I. , Zolk O. , Itter G. , Linz W. , Böhm M. Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts. J Mol Cell Cardiol 2002;34:151-63.

43.

Kim S. , HamaguchiA. , ShinkawaT. et al. Molecular effects of MI7055, furosemide and thiazide on cardiac hypertrophy of spontaneously hypertensive rats. J Pharmacol Exp Ther 1996; 279:983-90.